Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CGB-400 Topical Gel in Rosacea
NCT04886739Phase 2Completed
- Sponsor
- CAGE Bio
- Start
- May 2021
- Primary completion
- Dec 2021
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of choline geranate in rosacea, sponsored by CAGE Bio. Started May 2021; status: completed.
02
Drugs
choline geranate
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT04886739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04886739.